2022
DOI: 10.1038/s41523-022-00383-4
|View full text |Cite
|
Sign up to set email alerts
|

De-escalation in breast cancer surgery

Abstract: In recent years, several trials of breast cancer treatment have failed to demonstrate a survival benefit for some previously routine surgical therapies in selected patient groups. As each of these therapeutic approaches has been deemed of low value deimplementation has varied significantly. This demonstrates that effective de-escalation in breast cancer surgery relies on more than the availability of data from randomized controlled trials and other high-quality evidence, but is also influenced by various stake… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 34 publications
0
17
0
Order By: Relevance
“…23 Focus is henceforth shifting to de-escalation of surgery in the breast. 24 And although this direction is for both non-invasive and invasive cancers, non-operative management of invasive cancers pose greater challenges than that of non-invasive cancers.…”
Section: Discussionmentioning
confidence: 99%
“…23 Focus is henceforth shifting to de-escalation of surgery in the breast. 24 And although this direction is for both non-invasive and invasive cancers, non-operative management of invasive cancers pose greater challenges than that of non-invasive cancers.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, current recommendations for surgical de-escalation include the avoidance of unnecessary reexcisions for tumor-free but supposedly "close" margins after BCS. Further, experimental approaches such as omitting breast surgery altogether e.g., in selected women with DCIS or in case of a clinical complete response to PST, are currently under investigation [1,2]. BCS is in general accompanied by radiotherapy.…”
Section: Local Therapy Of the Breastmentioning
confidence: 99%
“…Most of these have focused on deimplementation of radiological imaging and preoperative workups, with less than 5% of recommendations targeting low-value surgical procedures thereby missing out on a great opportunity [4]. Some of these recommendations include avoiding axillary lymph node dissection in clinically node negative axilla in Stage I and II Carcinoma breast without sentinel lymph node assessment, avoiding routine Cholecystectomy in asymptomatic cholelithiasis and possibility of active surveillance for low grade localized carcinoma prostate [4,5]. It is clear that so much more can be done.…”
Section: What About Low Value Surgical Care?mentioning
confidence: 99%